| Ctr Eye Care, P. C. | |
|
120 E 200 N, Richfield, UT 84701-2144 | |
| (435) 896-2020 | |
| (435) 893-2174 |
| Full Name | Ctr Eye Care, P. C. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 120 E 200 N, Richfield, Utah |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144469305 | NPI | - | NPPES |
| 530428801004 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 47470887-9934 (Utah) | Primary |
| Provider Name | Harold Brent Parker |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1063526432 PECOS PAC ID: 4486867348 Enrollment ID: I20110201000173 |
News Archive
Antibodies produced during a previous case of COVID-19 or vaccine-induced immunity are targeted towards S protein, where the neutralizing antibodies attach to the Spike RBD domain. Some of the variants have mutations in their RBD domain, causing resistance to the neutralizing antibodies. However, the effect of these mutations on the affinity and kinetics of the binding of Spike RBD to ACE2 is not clear. A new study has been published on the bioRxiv* preprint server, which deals with the study of affinity and kinetic analysis of the interface between Spike RBD and ACE2 at physiological temperatures.
Celsion Corporation, a biotechnology drug development company, today announced financial results for the second quarter and six months ended June 30, 2010 and addressed the progression of the clinical trials of ThermoDox, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma and in a Phase I/II trial for patients with recurrent chest wall breast cancer.
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective factor that works against this inflammation.
In this Global Health Magazine opinion piece, Aaron Emmel, senior policy advisor at PATH, examines a momentum for reform in foreign aid that "has been mounting in both Congress and the Administration," writing, "Now we face one of the most austere budget environments in our nation's history, making the need for an efficient, accountable, transparent, effective, and strategic foreign assistance policy all the more important. Clearly, foreign aid needs to be reformed so that it can do the job it was originally intended for: assisting the people who need it most in the most efficient and effective way possible."
Scientists have used a computational model to show how depressive episodes affect the brain's ability to store and recall memories.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ctr Eye Care, P. C. 120 E 200 N, Richfield, UT 84701-2144 Ph: (435) 896-2020 | Ctr Eye Care, P. C. 120 E 200 N, Richfield, UT 84701-2144 Ph: (435) 896-2020 |
News Archive
Antibodies produced during a previous case of COVID-19 or vaccine-induced immunity are targeted towards S protein, where the neutralizing antibodies attach to the Spike RBD domain. Some of the variants have mutations in their RBD domain, causing resistance to the neutralizing antibodies. However, the effect of these mutations on the affinity and kinetics of the binding of Spike RBD to ACE2 is not clear. A new study has been published on the bioRxiv* preprint server, which deals with the study of affinity and kinetic analysis of the interface between Spike RBD and ACE2 at physiological temperatures.
Celsion Corporation, a biotechnology drug development company, today announced financial results for the second quarter and six months ended June 30, 2010 and addressed the progression of the clinical trials of ThermoDox, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma and in a Phase I/II trial for patients with recurrent chest wall breast cancer.
In type 2 diabetes, chronic inflammation drives cardiovascular disease, the leading cause of death among people with the condition. Researchers at Joslin Diabetes Center now have identified an unexpected natural protective factor that works against this inflammation.
In this Global Health Magazine opinion piece, Aaron Emmel, senior policy advisor at PATH, examines a momentum for reform in foreign aid that "has been mounting in both Congress and the Administration," writing, "Now we face one of the most austere budget environments in our nation's history, making the need for an efficient, accountable, transparent, effective, and strategic foreign assistance policy all the more important. Clearly, foreign aid needs to be reformed so that it can do the job it was originally intended for: assisting the people who need it most in the most efficient and effective way possible."
Scientists have used a computational model to show how depressive episodes affect the brain's ability to store and recall memories.
› Verified 7 days ago
Richard I Yardley, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 90 East Center, Richfield, UT 84701 Phone: 435-896-5671 Fax: 801-563-0200 | |
Dr. Harold Brent Parker, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 120 E 200 N, Richfield, UT 84701 Phone: 435-896-2020 Fax: 435-893-2174 | |
Todd Albrecht Od Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10 E 1300 S, Richfield, UT 84701 Phone: 435-893-8478 | |
Dr. David Mcclean Graf, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 145 N 100 E, Richfield, UT 84701 Phone: 435-896-8142 Fax: 435-896-9484 | |
Dr. Gary D Berger, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 10 E 1300 S, Richfield, UT 84701 Phone: 435-893-8478 | |
Valley Vision Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 145 N 100 E, Richfield, UT 84701 Phone: 435-896-8142 Fax: 435-896-9484 |